123 Main Street, New York, NY 10001
With demand for its tests and other molecular tools taking off in January 2020, CoDx’s stock soars more than 2000% in just over a week. And a new 91 Relative Strength Rating shows Co-Dx outperforming over 90% of all stocks. Investor’s Business Daily explores other key ratings and cites growing earnings and revenue increases as reasons to watch Co-Dx in the future.
Watch the video here:
https://finance.yahoo.com/video/believe-robust-testing-required-order-211813884.html
Co-Diagnostics, Inc.
2401 S. Foothill Dr. Suite D
Salt Lake City, UT 84109 USA
1 (801) 438-1036
info@co-dx.com
Co-Dx, Co-Primers, Logix Smart, Co-Dx Box, PCR Home, PCR Pro, and Vector Smart, and unless otherwise specified, all other product and service names appearing in this Internet site are trademarks owned by Co-Diagnostics, Inc., its subsidiaries or affiliates. No use of any Co-Diagnostic trademark, trade name, or trade dress in this site may be made without the prior written authorization of Co-Diagnostics, except to identify the product or services of the company.
TaqMan is a trademark of Roche Molecular Systems.